NON-COMMUNICABLE diseases (NCD) represent a major global health challenge, with significant mortality and morbidity. Among these, metabolic-associated steatotic liver disease (MASLD) and its more severe form, metabolic-associated steatohepatitis (MASH), have emerged as critical, but often under-recognised, public health threats. At this year’s European Association for the Study of the Liver (EASL) Congress, experts delivered insightful presentations on the topic.
No takes yet. Share an insight, caveat, or question.
Aleksandra Zurowska (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: